Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Breaking News

U.S. inflation "has likely resumed" slowing toward 2% - Fed's Waller

Divi's Laboratories Ltd. (DIVI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4,034.00 +107.55    +2.74%
05:59:45 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE361B01024 
S/N:  DIVISLAB
  • Volume: 15,335
  • Bid/Ask: 4,024.85 / 4,035.00
  • Day's Range: 3,870.00 - 4,035.30
Divi's Labs 4,034.00 +107.55 +2.74%

NS:DIVI Financials

 
A brief overview of the NS:DIVI financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Divi's Labs over time.

Divi's Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 19,090 million compared to INR 18,550 million a year ago. Revenue was INR 19,950 million compared to INR 19,350 million a year ago. Net income was INR 3,480 million compared to INR 4,930 million a year ago. Basic earnings per share from continuing operations was INR 13.11 compared to INR 18.6 a year ago. Diluted earnings per share from continuing operations was INR 13.11 compared to INR 18.6 a year ago.For the six months, sales was INR 36,870 million compared to INR 41,090 million a year ago. Revenue was INR 38,540 million compared to INR 42,780 million a year ago. Net income was INR 7,040 million compared to INR 11,960 million a year ago. Basic earnings per share from continuing operations was INR 26.52 compared to INR 45.04 a year ago. Diluted earnings per share from continuing operations was INR 26.52 compared to INR 45.04 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

DIVI Income Statement

Gross margin TTM 56.32%
Operating margin TTM 21.27%
Net Profit margin TTM 18.46%
Return on Investment TTM 9.76%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 18550 19090 17780 19508.7
Gross Profit 11260 10990 10900 9053.1
Operating Income 3940 3840 4110 4060.1
Net Income 3580 3480 3560 3209.7

DIVI Balance Sheet

Quick Ratio MRQ 5.41
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.04%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 142830 144387.7
Total Liabilities 16060 16716.8
Total Equity 126770 127670.9 127670.9

DIVI Cash Flow Statement

Cash Flow/Share TTM 56.98
Revenue/Share TTM 282.24
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DIVI Comments

Write your thoughts about Divi's Laboratories Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dinesh Chaudhari
Dinesh Chaudhari Apr 30, 2024 2:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Neuland Lab - price- 7500
Dinesh Chaudhari
Dinesh Chaudhari Apr 30, 2024 1:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target- 7000
invest market
INVEST2MARKETS Apr 02, 2024 11:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Update DIVISLAB Revised Stop Loss 3570 from 3510 (Profit +110, Even If Rev SL Hit)
invest market
INVEST2MARKETS Apr 01, 2024 11:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Update DIVISLAB Revised Stop Loss 3510 from 3364 (Profit +50, Even If Rev SL Hit)
invest market
INVEST2MARKETS Mar 31, 2024 11:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Delivery Buy DIVISLAB Above 3460 Stop Loss 3364 Target 3585+
Hemangi Patel
Hemangi Patel Dec 28, 2023 10:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sell on riseb,for 2000.
Dinesh Pathania
Dinesh Pathania May 24, 2023 7:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target for 3500
Shree ji Status
Shree ji Status Feb 08, 2023 8:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next target 3000
Yagnik Patel
Yagnik Patel Feb 03, 2023 4:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sale how much you can.put til last day of expiry.sure shot
Sourav Sourav
Sourav Sourav Dec 29, 2022 12:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
3700
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email